BBLG VS SRGA Stock Comparison
Performance
BBLG10/100
10/100
BBLG returned -94.35% in the last 12 months. Based on SPY's performance of 9.73%, its performance is below average giving it a score of 10 of 100.
SRGA10/100
10/100
SRGA returned -94.30% in the last 12 months. Based on SPY's performance of -3.90%, its performance is below average giving it a score of 10 of 100.
Technicals
BBLG14/100
14/100
BBLG receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.
SRGA14/100
14/100
SRGA receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.
Earnings
BBLG49/100
49/100
BBLG has missed earnings 2 times in the last 20 quarters.
SRGA44/100
44/100
SRGA has missed earnings 3 times in the last 20 quarters.
Profit
BBLG10/100
10/100
Out of the last 20 quarters, BBLG has had 1 profitable quarters and has increased their profits year over year on 1 of them.
SRGA35/100
35/100
Out of the last 20 quarters, SRGA has had 7 profitable quarters and has increased their profits year over year on 5 of them.
Volatility
BBLG46/100
46/100
BBLG has had a lower than average amount of volatility over the last 12 months giving it a score of 45 of 100.
SRGA57/100
57/100
SRGA has had a higher than average amount of volatility over the last 12 months giving it a score of 57 of 100.
All score calculations are broken down here to help you make more informed investing decisions
Bone Biologics Corp Common Stock Summary
Nasdaq / BBLG
Healthcare
Medical - Devices
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.
Surgalign Holdings, Inc. Common Stock Summary
Nasdaq / SRGA
Healthcare
Medical Devices
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare BBLG to other companies in the same or a similar industry.